• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1.25 Contact Hour(s)

    Release Date

    Sunday, August 28, 2022

    Offline Date

    Wednesday, August 28, 2024

    ACPE Expiration Date

    Friday, February 28, 2025

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $4.00

    • Overview

      While much of the industry’s attention in 2021 was focused on FDA decisions about COVID vaccines and related therapies, a total of 50 new drugs were approved in 2021, outpacing the 10-year average for FDA drug approvals. This session provides a broad overview of the drugs approved in 2021, which includes significant growth in monoclonal antibody approvals. This session is designed to be a cursory overview of new approvals, bringing forward the most actionable and relevant pieces for those practicing in today’s pharmacies. The session includes a look at the COVID related emergency use authorizations and approvals introduced in 2021 and reviews some of the more controversial decisions and challenges of the year.

      Handouts

      • Slide Document :   22080H01_2pp.pdf
      • Slide Document :   22080H01_6pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      For selected new medications approved in 2021, identify the burden-to-benefit ratio of therapy
      Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care
      Recognize the approved indication, common adverse effects, and drug interactions for new drugs approved by the FDA in 2021

      Pharmacy Technician

      For selected new medications approved in 2021, identify the burden-to-benefit ratio of therapy
      Recognize the approved indication, common adverse effects, and drug interactions for new drugs approved by the FDA in 2021
      Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care

      Nurse

      For selected new medications approved in 2021, identify the burden-to-benefit ratio of therapy
      Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care
      Recognize the approved indication, common adverse effects, and drug interactions for new drugs approved by the FDA in 2021
    • Activity Type

      Knowledge

      CE Broker

      20-919597

      Universal Activity Number

      Pharmacist 0798-0000-22-080-H01-P
      Pharmacy Technician 0798-0000-22-080-H01-T
      Nurse 0798-0000-22-080-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).